NASDAQ·US·Drug Manufacturers - General

AMGNAMGN

สรุป

เสี่ยง

ความมั่นใจ 89%
$338.02—

Today's session

Upside?
+26.8%
FV $428.59
P/E (TTM)?
23.8
Earnings yield
FCF yield?
4.1%
Mcap $182.22B

ถือ

Fundamental neutral·Technical neutral

What investors notice

Key signs

Plain-language read of the metrics that matter most for this stock.

Net positive
4 · 2 · 2

Strengths

4
  • Best-in-class return on equity111%
  • Pristine fundamentals (Piotroski 7+)8/9
  • Modestly undervalued vs. consensus FV27%
  • ROIC well above cost of capital — value-creating6%

Risks

2
  • Inconsistent profitability4/10
  • Highly leveraged (Net Debt > 4× EBITDA)4.2×

Watchlist

2
  • Gross margins under pressure
  • Long-term debt rising — monitor leverage
$338.02+20.8%

1Y · period change vs 2025-04-29

Score history (10y)

How quality has trended through cycles.

+1 YoY

Verdict bands: 85+ Wonderful · 70 Solid · 55 Average · 40 Risky.

Fair value range

5 of 5 models · trimmed-mean consensus

Consensus FV
$428.59
Upside
+26.8%
Now $338.02
Our FV$428.59
Price$338.02
$8.74$788.77

Open the Fair Value tab to tweak WACC and growth, and to see all five model outputs side-by-side.

10-year financials

Annual revenue, profit, and free cash flow with year-over-year growth overlay.

YoY growth overlaid

Snapshot

At a glance

Top-line figures most investors check first.

Market cap
$182.22B
P/E (TTM)?
23.8
FCF yield?
4.1%
Dividend
$9.52
2.8% yield
52w range
$254.30 – $388.16
Score confidence
89%
Data completeness

Last updated 4/30/2026, 5:21:13 AM · Data via Yahoo Finance, FMP, EDGAR. Disclaimer